IDEXX Laboratories Aktie
WKN: 888210 / ISIN: US45168D1046
04.08.2025 12:45:24
|
IDEXX Laboratories Inc Q2 Profit Increases, Beats Estimates
(RTTNews) - IDEXX Laboratories Inc (IDXX) revealed earnings for its second quarter that Increased from the same period last year and beat the Street estimates.
The company's bottom line totaled $293.99 million, or $3.63 per share. This compares with $203.30 million, or $2.44 per share, last year.
Excluding items, IDEXX Laboratories Inc reported adjusted earnings of $3.50 per share for the period.
Analysts on average had expected the company to earn $3.30 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 10.6% to $1.109 billion from $1.003 billion last year.
IDEXX Laboratories Inc earnings at a glance (GAAP) :
-Earnings: $293.99 Mln. vs. $203.30 Mln. last year. -EPS: $3.63 vs. $2.44 last year. -Revenue: $1.109 Bln vs. $1.003 Bln last year.
-Guidance: Full year EPS guidance: $12.40 - $12.76 Full year revenue guidance: $4,205 - $4,280 Mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 553,40 | 1,43% |
|